Cargando…

Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method

PURPOSE: Whether neoadjuvant chemotherapy (NCT) followed by concurrent chemoradiotherapy (CCRT) could improve survival in nasopharyngeal carcinoma (NPC) remains controversial especially in the era of intensity-modulated radiation therapy (IMRT), and we explored the role of NCT for NPC patients. PATI...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xueling, Zhu, Xiaodong, Liang, Zhongguo, Li, Ling, Qu, Song, Chen, Kaihua, Pan, Xinbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476787/
https://www.ncbi.nlm.nih.gov/pubmed/28652773
http://dx.doi.org/10.2147/OTT.S135590
_version_ 1783244665076580352
author Chen, Xueling
Zhu, Xiaodong
Liang, Zhongguo
Li, Ling
Qu, Song
Chen, Kaihua
Pan, Xinbin
author_facet Chen, Xueling
Zhu, Xiaodong
Liang, Zhongguo
Li, Ling
Qu, Song
Chen, Kaihua
Pan, Xinbin
author_sort Chen, Xueling
collection PubMed
description PURPOSE: Whether neoadjuvant chemotherapy (NCT) followed by concurrent chemoradiotherapy (CCRT) could improve survival in nasopharyngeal carcinoma (NPC) remains controversial especially in the era of intensity-modulated radiation therapy (IMRT), and we explored the role of NCT for NPC patients. PATIENTS AND METHODS: A retrospective review was conducted of 255 NPC patients treated with NCT+CCRT (n=67) or CCRT alone (n=188) based on IMRT between December 2006 and December 2012. To control the imbalance, a 1:2 match was performed using propensity score matching (PSM) method based on patient’s heterogeneity and regimens of concurrent chemotherapy (CCT). The long-term treatment outcomes and toxicity between NCT group (n=67) and concurrent chemoradiotherapy (CRT) group (n=134) after PSM were compared. RESULTS: The 5-year overall survival (OS), progression-free survival (PFS), recurrence-free survival (RFS), local recurrence-free survival (LRFS), regional recurrence-free survival (RRFS) and distant failure-free survival (DFFS) were 78.8%, 69.1%, 90.0%, 90.0%, 100% and 78.3% for NCT group, while 79.5%, 75.7%, 92.7%, 94.2%, 96.1% and 82.7% for CRT group (P=0.305, 0.448, 0.790, 0.512, 0.104 and 0.671). It indicated that the treatment method (NCT+CCRT vs CCRT) was not the independent prognostic factor for the survival in NPC patients, and only patients who had completed at least two cycles of CCT got better OS, RFS and DFFS (P=0.009, 0.016 and 0.043), whether to receive NCT or not. No difference in the incidences of any acute and most late toxicity between the two groups was shown. CONCLUSION: Our study did not show the exact advantage of NCT followed by CCRT compared with CCRT alone or higher incidences of toxicity in NCT group. It suggests that NCT might not be necessary if two or more cycles of CCT are finished well in the era of IMRT, and when NCT is finished well, less than two cycles of CCT with IMRT could be enough. However, in the era of IMRT, the role of NCT still needs to be further explored.
format Online
Article
Text
id pubmed-5476787
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-54767872017-06-26 Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method Chen, Xueling Zhu, Xiaodong Liang, Zhongguo Li, Ling Qu, Song Chen, Kaihua Pan, Xinbin Onco Targets Ther Original Research PURPOSE: Whether neoadjuvant chemotherapy (NCT) followed by concurrent chemoradiotherapy (CCRT) could improve survival in nasopharyngeal carcinoma (NPC) remains controversial especially in the era of intensity-modulated radiation therapy (IMRT), and we explored the role of NCT for NPC patients. PATIENTS AND METHODS: A retrospective review was conducted of 255 NPC patients treated with NCT+CCRT (n=67) or CCRT alone (n=188) based on IMRT between December 2006 and December 2012. To control the imbalance, a 1:2 match was performed using propensity score matching (PSM) method based on patient’s heterogeneity and regimens of concurrent chemotherapy (CCT). The long-term treatment outcomes and toxicity between NCT group (n=67) and concurrent chemoradiotherapy (CRT) group (n=134) after PSM were compared. RESULTS: The 5-year overall survival (OS), progression-free survival (PFS), recurrence-free survival (RFS), local recurrence-free survival (LRFS), regional recurrence-free survival (RRFS) and distant failure-free survival (DFFS) were 78.8%, 69.1%, 90.0%, 90.0%, 100% and 78.3% for NCT group, while 79.5%, 75.7%, 92.7%, 94.2%, 96.1% and 82.7% for CRT group (P=0.305, 0.448, 0.790, 0.512, 0.104 and 0.671). It indicated that the treatment method (NCT+CCRT vs CCRT) was not the independent prognostic factor for the survival in NPC patients, and only patients who had completed at least two cycles of CCT got better OS, RFS and DFFS (P=0.009, 0.016 and 0.043), whether to receive NCT or not. No difference in the incidences of any acute and most late toxicity between the two groups was shown. CONCLUSION: Our study did not show the exact advantage of NCT followed by CCRT compared with CCRT alone or higher incidences of toxicity in NCT group. It suggests that NCT might not be necessary if two or more cycles of CCT are finished well in the era of IMRT, and when NCT is finished well, less than two cycles of CCT with IMRT could be enough. However, in the era of IMRT, the role of NCT still needs to be further explored. Dove Medical Press 2017-06-09 /pmc/articles/PMC5476787/ /pubmed/28652773 http://dx.doi.org/10.2147/OTT.S135590 Text en © 2017 Chen et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Chen, Xueling
Zhu, Xiaodong
Liang, Zhongguo
Li, Ling
Qu, Song
Chen, Kaihua
Pan, Xinbin
Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method
title Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method
title_full Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method
title_fullStr Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method
title_full_unstemmed Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method
title_short Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method
title_sort long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (ccrt) vs ccrt alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476787/
https://www.ncbi.nlm.nih.gov/pubmed/28652773
http://dx.doi.org/10.2147/OTT.S135590
work_keys_str_mv AT chenxueling longtermoutcomesofneoadjuvantchemotherapyfollowedbyconcurrentchemoradiotherapyccrtvsccrtalonefornasopharyngealcarcinomaintheeraofintensitymodulatedradiationtherapyusingpropensityscorematchingmethod
AT zhuxiaodong longtermoutcomesofneoadjuvantchemotherapyfollowedbyconcurrentchemoradiotherapyccrtvsccrtalonefornasopharyngealcarcinomaintheeraofintensitymodulatedradiationtherapyusingpropensityscorematchingmethod
AT liangzhongguo longtermoutcomesofneoadjuvantchemotherapyfollowedbyconcurrentchemoradiotherapyccrtvsccrtalonefornasopharyngealcarcinomaintheeraofintensitymodulatedradiationtherapyusingpropensityscorematchingmethod
AT liling longtermoutcomesofneoadjuvantchemotherapyfollowedbyconcurrentchemoradiotherapyccrtvsccrtalonefornasopharyngealcarcinomaintheeraofintensitymodulatedradiationtherapyusingpropensityscorematchingmethod
AT qusong longtermoutcomesofneoadjuvantchemotherapyfollowedbyconcurrentchemoradiotherapyccrtvsccrtalonefornasopharyngealcarcinomaintheeraofintensitymodulatedradiationtherapyusingpropensityscorematchingmethod
AT chenkaihua longtermoutcomesofneoadjuvantchemotherapyfollowedbyconcurrentchemoradiotherapyccrtvsccrtalonefornasopharyngealcarcinomaintheeraofintensitymodulatedradiationtherapyusingpropensityscorematchingmethod
AT panxinbin longtermoutcomesofneoadjuvantchemotherapyfollowedbyconcurrentchemoradiotherapyccrtvsccrtalonefornasopharyngealcarcinomaintheeraofintensitymodulatedradiationtherapyusingpropensityscorematchingmethod